secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001837607-25-000015
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma posts corporate presentation; details limited
------------------------------------------------------------

- Presentation made available on IR website on March 10, 2025.
- Focus on PrabotulinumtoxinA as a potential biosimilar for therapeutic indications.
- No specific financial, clinical, or operational data disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000015/0001837607-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000015/aeon-20250310x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer